Biochemical Changes in Methotrexate Users in Combination with Leflunomide for Rheumatoid Arthritis
DOI:
https://doi.org/10.33448/rsd-v9i10.9150Keywords:
Rheumatoid Arthritis; Biochemical Changes; Methotrexate; Leflunomide.Abstract
Objective. To analyze the biochemical changes of patients with Teresina-PI CEAF using methotrexate monotherapy and in combination with leflunomide for the treatment of rheumatoid arthritis. Methods. The research was characterized in a cross-sectional, descriptive study, with a quantitative and qualitative approach where data collection was carried out by searching the National System of Management of Pharmaceutical Services - HORUS and through consultations of the documentary records of users assisted by CEAF based on therapeutic treatment, drug interference in laboratory parameters, treatment time, sex and changes in therapeutic treatment. All statistical analyses were performed using the Statistical Package for the Social Science (SPSS) software, to obtain these analyses we used the Mann-Whitney U test for independent variables with a 95% confidence level. For a significant result, the p-value needs to be lower than the significance level α=0.05. Results. 98 patients selected for the study, 90,81 % were female, 9.18 % male, in relation to drug treatment there were similarities with the characteristic findings, 92.85 % of these patients were using MTX + LEF with association and 7.14 % were using monotherapy with MTX. The patients in both treatment presented alterations in laboratory parameters at the two time intervals, with a greater change in liver enzymes AST/ALT in the shortest period of time, creatinine was the test that showed the least alteration, with a slight change in patients on associated treatment in the period of time greater than one year. Conclusion. In view of the analysis of the results, it was found that there was no statistically significant difference between the laboratory parameters analyzed: liver enzymes AST / ALT, hemoglobin and creatinine of patients treated with MTX in isolated therapy and with MTX associated with LEF.
References
Alves, J. A. N. R. et al. (2011). Toxicidade hepática é rara em pacientes com artrite reumatoide usando terapia combinada de leflunomida e metotrexato. Rev. Bras. Reumatol., 51 (2), 141-144.
Bagatini, F.et al. (2011). Potenciais interações medicamentosas em pacientes com artrite reumatoide. Rev. Bras. Reumatol, 51 (1), 29-39.
Brasil. Ministério da Saúde. (2019). Protocolo Clínico e Diretrizes Terapêuticas da Artrite Reumatoide.
David, J. M. et al. (2013). Estudo clínico e laboratorial de pacientes com artrite reumatoide diagnosticados em serviços de reumatologia em Cascavel, PR, Brasil. Rev. Bras. Reumatol, 53 (1), 57-65.
Fernandes, V. et al. (2011). Uso de terapias biológicas no tratamento da artrite reumatoide: comparação entre as principais recomendações mundiais e a brasileira. Rev. Bras. Reumatol,51 (3), 225-230.
Goeldner, I. et al. (2011). Artrite reumatoide: uma visão atual. Jornal Brasileiro de Patologia e Medicina Laboratorial, Rio de Janeiro. 47 (5), 495-503.
Londono, J. et al. (2012). Eficácia terapêutica e segurança de metotrexato + leflunomida em pacientes colombianos com artrite reumatoide ativa refratária ao tratamento convencional. Rev. Bras. Reumatol, 52 (6), 830-845.
Louzada, J. P. et al. (2007) Análise descritiva das características demográficas e clínicas de pacientes com artrite reumatoide no estado de São Paulo, Brasil. Rev. Bras. Reumatol, 47 (2), 84-90.
Mota, L. M. H. et al. (2012). Consenso 2012 da Sociedade Brasileira de Reumatologia para o tratamento da artrite reumatoide. Rev. Bras. Reumatol, 52, (2), 135-174.
Silva, M.C.A. et al. (2005). Ageusia e anosmia na vigência de tratamento com leflunomida para artrite reumatoide (AR). Rev. Bras. Reumatol, 45 (6), XVI-XVII.
Ganna, S. (2014a). Prevalência de anemia na artrite reumatoide. Rev. Bras. Reumatol, 54, (4), 257-259.
Ganna, S. (2014b). Relação entre o nível de hemoglobina e atividade da doença em pacientes com artrite reumatoide. Rev. Bras. Reumatol, 54 (6), 437-440.
Toth, P & Bernd, R. (2014). Leucopenia grave em paciente com artrite reumatoide tratada com combinação de metotrexato e leflunomida. Rev. Bras. Reumatol, 54 (2), 152-154.
Vieira, F.S. et al. (2013). Financiamento da assistência farmacêutica no sistema único de saúde. Saúde Soc, 22 (1), 73-84.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2020 Safira Roland; Ricardo de Paulo Lopes; Wanderley do Nascimento Júnior; Wanderson Lima do Nascimento; Joseana Martins Soares de Rodrigues Leitão
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
